kadobarofficial.com – FDA Warning Letter, May 1, 2026

On May 1, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to kadobarofficial.com following a review of the company’s website. The FDA determined that the firm is distributing unauthorized nicotine pouch products, specifically citing the "Peach Pineapple Mint Kado Bar Nicotine Pouches," to customers within the United States. Under the regulatory framework of the Federal Food, Drug, and Cosmetic Act (FD&C Act), these nicotine-containing items are classified as tobacco products. To be legally marketed, any "new" tobacco product—those introduced or modified after February 15, 2007—must receive a formal premarket authorization order from the FDA. Because the company failed to obtain this authorization, the products are considered adulterated and misbranded. The FDA requires kadobarofficial.com to take immediate action to address these violations. The company must submit a written response within 15 working days detailing the steps taken to correct the issues, including the dates they stopped selling the unauthorized products and a long-term plan for maintaining compliance. Failure to comply with these federal regulations may result in severe consequences, such as civil money penalties, product seizures, or legal injunctions.